RANDOX RX DAYTONA— 510(k) K024014

Name: FDA 510(k) clearance K024014
Creator: U.S. Food and Drug Administration
Published: 2003-12-04

Substantially Equivalent

Randox Laboratories, Ltd.

FDA 510(k) clearance K024014 for RANDOX RX DAYTONA, Substantially Equivalent on 2003-12-04. Applicant: Randox Laboratories, Ltd.. Device class: 2.

Clearance details

Applicant: Randox Laboratories, Ltd.
Product code: Code CGA
Device class: Class 2
Regulation: 21 CFR 862.1345
Advisory panel: Clinical Chemistry
Date received: 2002-12-04
Decision date: 2003-12-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Crumlin, GB

Download summary PDF View on FDA.gov ↗

Recent devices under product code CGA

view all

K252488 — ABL90 FLEX PLUS System2026-05-01
K210933 — YSI 2900C Biochemistry Analyzer2024-09-30
K220328 — EasyStat 3002024-07-26
K223179 — Cholestech LDX System2023-09-20
K223755 — i-STAT G cartridge with the i-STAT 1 System2023-09-11

More clearances from Randox Laboratories, Ltd.

view all

DEN240035 — ConcizuTrace ELISA2025-05-22
K230890 — ISE Electrodes2023-09-08
K182042 — Randox Calcium (Ca)2018-10-23
K162200 — Randox RX Daytona Plus Magnesium (MG)2017-04-28
K152085 — Liquid CO2-2 (LCO2-2)2016-02-24

Adverse events under product code CGA

product code CGA

Death: 2
Malfunction: 1,816
Total: 1,818

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K024014

K-number listed on FDA's recall record

Z-0198-2024 — RX Daytona Plus (with ISE)-IVD Clinical Chemistry Analyser Catalog Number: RX4040Class II·Ongoing·Randox Laboratories Ltd.·20230906

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K024014.

Data sourced from openFDA. This site is unofficial and independent of the FDA.